Table 1.
Demographic characteristics of participants at enrollment.
| GBP510 10 µg with AS03 (N = 101) |
GBP510 10 µg (N = 10) |
GBP510 25 µg with AS03 (N = 104) |
GBP510 25 µg (N = 52) |
Placebo (N = 61) |
Total (N = 328) |
|
|---|---|---|---|---|---|---|
| Age (years) | ||||||
| Mean ± SD | 45·0 ± 14·9 | 38·7 ± 8·7 | 43·9 ± 14·2 | 43·2 ± 15·3 | 43·3 ± 14·7 | 43·9 ± 14·5 |
| Median (range) | 44·0 (21·0–76·0) | 40·1 (24·0–50·0) | 42·0 (19·0–74·0) | 42·0 (19·0–73·0) | 42·0 (19·0–80·0) | 42·0 (19·0–80·0) |
| Age, n (%) | ||||||
| 19–64 years | 88 (87·1) | 10 (100) | 92 (88·5) | 47 (90·4) | 56 (91·8) | 293 (89·3) |
| 65–85 years | 13 (12·9) | 0 (0) | 12 (11·5) | 5 (9·6) | 5 (8·2) | 35 (10·7) |
| Sex, n (%) | ||||||
| Male | 51 (50·5) | 3 (30·0) | 45 (43·3) | 23 (44·2) | 26 (42·6) | 148 (45·1) |
| Female | 50 (49·5) | 7 (70·0) | 59 (56·7) | 29 (55·8) | 35 (57·4) | 180 (54·9) |
| BMI (kg/m2) | ||||||
| Mean ± SD | 24·0 ± 2·8 | 23·3 ± 2·3 | 24·1 ± 2·6 | 23·8 ± 2·9 | 23·8 ± 2·6 | 23·9 ± 2·7 |
| Median (range) | 24·2 (18·4–29·9) | 23·0 (20·2–26·6) | 23·8 (18·0–29·6) | 24·2 (18·4–29·9) | 24·0 (18·0–28·2) | 24·1 (18·0–29·9) |
SD, standard deviation; BMI, body mass index.